Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04547790 · ClinicalTrials.gov registry record · NA

A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

A NA study of Type2 Diabetes, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
101
Enrollment target
1
Study location

NCT04547790 is a NA study of Type2 Diabetes that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 47,818-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04547790, a NA study of Type2 Diabetes, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine which of Psyllium and Wheat Dextrin is more effective in lowering fasting blood sugar and hemoglobin A1c, and to evaluate the effects they have on laboratory values.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Psyllium
  • DIETARY_SUPPLEMENT Wheat Dextrin

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2020-12-23
Est. Completion 2023-11-27
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04547790

The ClinicalTrials.gov registry entry for NCT04547790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 47,818-participant average among 20 other Type2 Diabetes trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Psyllium is the first listed.

NCT04547790 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04547790 about?

NCT04547790 is a clinical study titled "A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2". The purpose of this study is to determine which of Psyllium and Wheat Dextrin is more effective in lowering fasting blood sugar and hemoglobin A1c, and to evaluate the effects they have on laboratory values.

What is the current status of trial NCT04547790?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2020-12-23. Estimated completion is 2023-11-27.

What conditions does trial NCT04547790 study?

This clinical trial studies the following conditions: Type2 Diabetes.

What interventions are being tested in trial NCT04547790?

The interventions under investigation include: Psyllium (DIETARY_SUPPLEMENT), Wheat Dextrin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04547790?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04547790 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.